Graduate School
Albert Einstein College of Medicine (2005), Cell Biology
Medical School
Albert Einstein College of Medicine (2005)
University of Texas MD Anderson Cancer Center (2006), Internal Medicine
UT MD Anderson Cancer Center (2010), Radiation Oncology

Research Interest

  • Inflammation and Lung Cancer
  • Lung Cancer Radiation Resistance
  • Metabolic Dysregulation and Lung Cancer
  • Oligometastatic Lung Cancer and Treatment with Radiation
  • Pathophysiology and Biology of Cachexia


Featured Publications LegendFeatured Publications

Optic Neuropathy and Blindness Associated With Crizotinib for Non-Small-Cell Lung Cancer With EML4-ALK Translocation.
Chun SG, Iyengar P, Gerber DE, Hogan RN, Timmerman RD J. Clin. Oncol. 2014 Mar
Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study.
Cannon NA, Iyengar P, Choy H, Timmerman R, Meyer J BMC Cancer 2014 14 971
Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer.
Iyengar P, Westover K, Timmerman RD Semin Respir Crit Care Med 2013 Dec 34 6 845-54
Localization accuracy and immobilization effectiveness of a stereotactic body frame for a variety of treatment sites.
Foster R, Meyer J, Iyengar P, Pistenmaa D, Timmerman R, Choy H, Solberg T Int. J. Radiat. Oncol. Biol. Phys. 2013 Dec 87 5 911-6
The Role of Inflammatory Pathways in Cancer Associated Cachexia and Radiation Resistance.
Laine A, Iyengar P, Pandita TK Mol. Cancer Res. 2013 Jun
Locally advanced lung cancer: an optimal setting for vaccines and other immunotherapies.
Iyengar P, Gerber DE Cancer J 2013 May-Jun 19 3 247-62
Histone modifications and DNA double-strand break repair after exposure to ionizing radiations.
Hunt CR, Ramnarain D, Horikoshi N, Iyengar P, Pandita RK, Shay JW, Pandita TK Radiat. Res. 2013 Apr 179 4 383-92
Design of an expert system for mitigating trace element toxicity in cancer risk management.
Krishna Kumar PT, Vinod PT, Phoha VV, Iyengar SS, Iyengar P Cancer Inform 2013 12 21-9
Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?
Chun SG, Choe KS, Iyengar P, Yordy JS, Timmerman RD Cancer Biol. Ther. 2012 Dec 13 14 1376-83
Stereotactic ablative radiotherapy for non-small cell lung cancer: rationale and outcomes.
Iyengar P, Timmerman RD J Natl Compr Canc Netw 2012 Dec 10 12 1514-20

Honors & Awards

  • American Society of Therapeutic Radiation Oncology
    Plenary Speaker (2017)
  • ARRO
    Educator of the Year Teaching Award (2017)
  • American Cancer Society
    Research Scholar (2015)
  • Sidney Kimmel Cancer Research Foundation
    Translational Research Award (2013)
  • UT Southwestern Medical Center
    President Research Council Distinguished Research Award (2012)
  • Lung Cancer Research Foundation
    Research Award (2011)
  • National Lung Cancer Partnership
    Young Investigator Research Award (2011)
  • Radiological Society of North America
    RSNA Research Grant Award Winner (2011)
  • Roentgen Research Award, RSNA Research and Education Foundation
    Research Resident Award (2010)
  • NIH Medical Scientist Training Program
    MD/PhD Program (2005)
  • ECOG Young Investigator Award cosponsored by Aventis

Professional Associations/Affiliations

  • American Society of Clinical Oncology
  • American Society of Therapeutic Radiology and Oncology
  • Free to Breathe
  • International Association for the Study of Lung Cancer
  • Lung Cancer Research Foundation
  • NRG Oncology
  • Radiation Therapy Oncology Group
  • Radiological Society of North America